BIOMAT Database Logo BIOMAT Database Logo

Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. II. General pathologic, neuropathologic, and biochemical aspects. 1977

H H Schaumburg, and J M Powers, and C S Raine, and P S Spencer, and J W Griffin, and J W Prineas, and D M Boehme

Histopathologic features were studied in postmortem examination of two men with adrenomyeloneuropathy, and biochemical studies were performed on one of these individuals. The histopathologic picture of one case included dying-back features in the nervous system and lamellar cytoplasmic inclusions in the brain, adrenal gland, and testis similar to those in adrenoleukodystrophy. Biochemical studies of the cerebral white matter of this individual revealed increased amounts of long-chain saturated fatty acids in cholesterol esters, an abnormality characteristic of adrenoleukodystrophy. Despite differences in clinical presentation and neuropathology, adrenomyeloneuropathy probably represents a distinct variant of adrenoleukodystrophy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009128 Muscle Spasticity A form of muscle hypertonia associated with upper MOTOR NEURON DISEASE. Resistance to passive stretch of a spastic muscle results in minimal initial resistance (a "free interval") followed by an incremental increase in muscle tone. Tone increases in proportion to the velocity of stretch. Spasticity is usually accompanied by HYPERREFLEXIA and variable degrees of MUSCLE WEAKNESS. (From Adams et al., Principles of Neurology, 6th ed, p54) Clasp-Knife Spasticity,Spastic,Clasp Knife Spasticity,Spasticity, Clasp-Knife,Spasticity, Muscle
D010525 Peripheral Nerves The nerves outside of the brain and spinal cord, including the autonomic, cranial, and spinal nerves. Peripheral nerves contain non-neuronal cells and connective tissue as well as axons. The connective tissue layers include, from the outside to the inside, the epineurium, the perineurium, and the endoneurium. Endoneurium,Epineurium,Perineurium,Endoneuriums,Epineuriums,Nerve, Peripheral,Nerves, Peripheral,Perineuriums,Peripheral Nerve
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D002479 Inclusion Bodies A generic term for any circumscribed mass of foreign (e.g., lead or viruses) or metabolically inactive materials (e.g., ceroid or MALLORY BODIES), within the cytoplasm or nucleus of a cell. Inclusion bodies are in cells infected with certain filtrable viruses, observed especially in nerve, epithelial, or endothelial cells. (Stedman, 25th ed) Cellular Inclusions,Cytoplasmic Inclusions,Bodies, Inclusion,Body, Inclusion,Cellular Inclusion,Cytoplasmic Inclusion,Inclusion Body,Inclusion, Cellular,Inclusion, Cytoplasmic,Inclusions, Cellular,Inclusions, Cytoplasmic
D003711 Demyelinating Diseases Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system. Clinically Isolated CNS Demyelinating Syndrome,Clinically Isolated Syndrome, CNS Demyelinating,Demyelinating Disorders,Demyelination,Demyelinating Disease,Demyelinating Disorder,Demyelinations
D005227 Fatty Acids Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed) Aliphatic Acid,Esterified Fatty Acid,Fatty Acid,Fatty Acids, Esterified,Fatty Acids, Saturated,Saturated Fatty Acid,Aliphatic Acids,Acid, Aliphatic,Acid, Esterified Fatty,Acid, Saturated Fatty,Esterified Fatty Acids,Fatty Acid, Esterified,Fatty Acid, Saturated,Saturated Fatty Acids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H H Schaumburg, and J M Powers, and C S Raine, and P S Spencer, and J W Griffin, and J W Prineas, and D M Boehme
Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. I. Clinical and endocrinologic aspects.
December 1977, Neurology,
H H Schaumburg, and J M Powers, and C S Raine, and P S Spencer, and J W Griffin, and J W Prineas, and D M Boehme
A variant of adrenomyeloneuropathy in a family with adrenoleukodystrophy and adrenomyeloneuropathy.
September 1994, The Journal of the American Osteopathic Association,
H H Schaumburg, and J M Powers, and C S Raine, and P S Spencer, and J W Griffin, and J W Prineas, and D M Boehme
Adrenomyeloneuropathy. A protracted, pseudosystematic variant of adrenoleukodystrophy.
January 1980, Acta neuropathologica,
H H Schaumburg, and J M Powers, and C S Raine, and P S Spencer, and J W Griffin, and J W Prineas, and D M Boehme
Clinical aspects of adrenoleukodystrophy and adrenomyeloneuropathy.
January 1991, Developmental neuroscience,
H H Schaumburg, and J M Powers, and C S Raine, and P S Spencer, and J W Griffin, and J W Prineas, and D M Boehme
Clinical and therapeutic aspects of adrenoleukodystrophy and adrenomyeloneuropathy.
September 1995, Journal of neuropathology and experimental neurology,
H H Schaumburg, and J M Powers, and C S Raine, and P S Spencer, and J W Griffin, and J W Prineas, and D M Boehme
[Adrenoleukodystrophy and adrenomyeloneuropathy].
June 1986, Presse medicale (Paris, France : 1983),
H H Schaumburg, and J M Powers, and C S Raine, and P S Spencer, and J W Griffin, and J W Prineas, and D M Boehme
[Adrenoleukodystrophy and adrenomyeloneuropathy. Clinical biochemical and molecular genetic findings].
February 1998, Der Nervenarzt,
H H Schaumburg, and J M Powers, and C S Raine, and P S Spencer, and J W Griffin, and J W Prineas, and D M Boehme
[Adrenoleukodystrophy and adrenomyeloneuropathy--clinical spectrum, pathobiochemical aspects, diagnosis and therapy].
December 1989, Fortschritte der Neurologie-Psychiatrie,
H H Schaumburg, and J M Powers, and C S Raine, and P S Spencer, and J W Griffin, and J W Prineas, and D M Boehme
New phenotypic variant of adrenoleukodystrophy. Pathologic, ultrastructural, and biochemical study in two brothers.
March 1980, Journal of the neurological sciences,
H H Schaumburg, and J M Powers, and C S Raine, and P S Spencer, and J W Griffin, and J W Prineas, and D M Boehme
Neonatal adrenoleukodystrophy: a clinical, pathologic, and biochemical study.
November 2012, Pediatric neurology,
Copied contents to your clipboard!